A 5-year randomized trial on the safety and efficacy of pimecrolimus in atopic dermatitis: a critical appraisal - comment.

2.50
Hdl Handle:
http://hdl.handle.net/11287/620471
Title:
A 5-year randomized trial on the safety and efficacy of pimecrolimus in atopic dermatitis: a critical appraisal - comment.
Authors:
Charman, Carolyn
Citation:
A 5-year randomized trial on the safety and efficacy of pimecrolimus in atopic dermatitis: a critical appraisal - comment. 2017, 177 (4):1004-1005 Br. J. Dermatol.
Publisher:
Wiley
Journal:
The British Journal of Dermatology
Issue Date:
Oct-2017
URI:
http://hdl.handle.net/11287/620471
DOI:
10.1111/bjd.15848
PubMed ID:
28858382
Additional Links:
http://dx.doi.org/10.1111/bjd.15848
Type:
Comment
Language:
en
ISSN:
1365-2133
Appears in Collections:
Dermatology; 2017 RD&E publications

Full metadata record

DC FieldValue Language
dc.contributor.authorCharman, Carolynen
dc.date.accessioned2017-10-24T14:29:53Z-
dc.date.available2017-10-24T14:29:53Z-
dc.date.issued2017-10-
dc.identifier.citationA 5-year randomized trial on the safety and efficacy of pimecrolimus in atopic dermatitis: a critical appraisal - comment. 2017, 177 (4):1004-1005 Br. J. Dermatol.en
dc.identifier.issn1365-2133-
dc.identifier.pmid28858382-
dc.identifier.doi10.1111/bjd.15848-
dc.identifier.urihttp://hdl.handle.net/11287/620471-
dc.language.isoenen
dc.publisherWileyen
dc.relation.urlhttp://dx.doi.org/10.1111/bjd.15848en
dc.rightsArchived with thanks to The British journal of dermatologyen
dc.subjectWessex Classification Subject Headings::Dermatologyen
dc.titleA 5-year randomized trial on the safety and efficacy of pimecrolimus in atopic dermatitis: a critical appraisal - comment.en
dc.typeCommenten
dc.identifier.journalThe British Journal of Dermatologyen
dc.type.versionPublisheden

Related articles on PubMed

All Items in RD&E Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.